For people with type 1 diabetes
Learn more For kids Getting started Switching and upgrades Infusion Sets Flex payment plan WebinarsFor people with type 2 diabetes
Learn more 30 day evaluation program - type 2 diabetes Switching and upgrades Infusion Sets Flex payment plan WebinarsFor people who take multiple daily injections
Learn more Why InPen™ Get started with InPen™ Smart MDI CliniciansInjection port that lets you take your medication without having to puncture your skin for each shot
Learn more 30 day evaluation program Watch videoConverts data from your device into easy to understand insights about your sugar levels
Learn more Create an account For customers Login CareLink™ software support User guides and manuals FAQsThe following media kits are made available to provide reporters with background information on the range of Medtronic diabetes therapies and the conditions they treat.
Information about the MiniMed™ 770G system which features smartphone connectivity and an expanded age indication down to the age of 2 years old.
Information about the InPen™ smart insulin pen system.
Information about the MiniMed™ 670G system, the world’s first hybrid closed loop system for individuals with type 1 diabetes.
Information about the Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart standalone CGM system to help people with diabetes using multiple daily injections (MDI) stay ahead of high and low glucose events.^
Information about Medtronic insulin pump therapy, continuous glucose monitoring and therapy management software.
References
* Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.
^ Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ™ insights that can inform users of clinically relevant glucose patterns.